Presymptomatic Parkinson's disease: the Arizona experience
- PMID: 22166435
- DOI: 10.1016/S1353-8020(11)70063-3
Presymptomatic Parkinson's disease: the Arizona experience
Abstract
There is a growing interest in presymptomatic diagnosis of Parkinson's disease (PD), but the best and most practical method to screen and confirm asymptomatic individuals for PD needs further study. The Banner-Sun Health Brain and Body Donation program in Sun City, Arizona has studied primarily PD and Alzheimer's disease. Enrollees receive annual prospective standardized evaluation that includes clinical, biomarker testing, and at autopsy, neuropathological examination is performed followed by a consensus conference that determines final diagnosis. Since numerous Controls receive these assessments, these subjects become an excellent cohort to study presymptomatic PD. We found that Controls with partial diagnostic criteria for PD (1 of either rest tremor or bradykinesia) had a 6.6 relative risk for eventually developing full diagnostic criteria for PD. Neuropathologic examination has uncovered cases of "incidental Lewy body disease" (ILBD). We have shown that ILBD cases during life demonstrated no significant differences in clinical assessment versus similarly assessed controls. However, electrophysiological assessment showed subclinical low frequency rest discharges in some ILBD cases. Electroencephalography spectral frequency of ILBD cases was lower than for controls but not as low as for PD cases. The longitudinal assessments of this brain bank offer significant opportunities for the study of presymptomatic PD.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.Acta Neuropathol. 2008 Apr;115(4):437-44. doi: 10.1007/s00401-008-0345-7. Epub 2008 Feb 9. Acta Neuropathol. 2008. PMID: 18264713
-
Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts.Eur J Neurol. 2016 Feb;23(2):387-92. doi: 10.1111/ene.12878. Epub 2015 Oct 31. Eur J Neurol. 2016. PMID: 26518336
-
Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.Acta Neuropathol. 2003 Sep;106(3):191-201. doi: 10.1007/s00401-003-0725-y. Epub 2003 Jul 5. Acta Neuropathol. 2003. PMID: 12845452
-
Clinical criteria for the diagnosis of Parkinson's disease.Neurodegener Dis. 2010;7(5):284-90. doi: 10.1159/000314478. Epub 2010 Jul 9. Neurodegener Dis. 2010. PMID: 20616563 Review.
-
Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease.Mov Disord. 1995 Mar;10(2):188-94. doi: 10.1002/mds.870100209. Mov Disord. 1995. PMID: 7753061 Review.
Cited by
-
Neuropathology of incidental Lewy body & prodromal Parkinson's disease.Mol Neurodegener. 2023 May 12;18(1):32. doi: 10.1186/s13024-023-00622-7. Mol Neurodegener. 2023. PMID: 37173733 Free PMC article. Review.
-
Quantitative proteomics in A30P*A53T α-synuclein transgenic mice reveals upregulation of Sel1l.PLoS One. 2017 Aug 3;12(8):e0182092. doi: 10.1371/journal.pone.0182092. eCollection 2017. PLoS One. 2017. PMID: 28771510 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical